Clinical Trials Browser

Completed × Lymphoma, T-Cell, Peripheral × HBI-8000 × Clear all

NCT02953652 2024-09-19

Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Completed

55 enrolled 18 charts

Lymphoma, T-Cell, Peripheral